Sonia Gulati
Amministratore Delegato presso Leukovet
Patrimonio netto: 185 610 $ in data 31/01/2023
Profilo
Sonia Gulati is currently the Chief Executive Officer & Director at Leukovet.
She is also a Director at TigaTx, Inc. and an Investment Review Committee Member at Accelerate Long Island (Venture Capital).
Previously, she was a Director at Actinobac Biomed, Inc., Pinpoint Therapeutics, Inc., and 1200 Pharma LLC.
She was also an Assistant Director at New York Ventures.
Dr. Gulati received her undergraduate degree from Barnard College and her doctorate from Columbia University School of the Arts in 2011.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
HOMESFY REALTY LTD.
1.16% | 02/01/2023 | 35 511 ( 1.16% ) | 185 610 $ | 31/01/2023 |
Posizioni attive di Sonia Gulati
| Società | Posizione | Inizio |
|---|---|---|
Leukovet
 Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Amministratore Delegato | - |
Accelerate Long Island (Venture Capital)
 Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island/venture capital/ (Accelerate Long Island (Venture Capital)) is a venture capital firm, a subsidiary of Accelerate Long Island, Inc founded in 2016. The firm is headquartered in Melville, New York. | Investitore di Private Equity | - |
TigaTx, Inc.
 TigaTx, Inc. BiotechnologyHealth Technology TigaTx, Inc. is a biotechnology company that focuses on developing first-in-class, engineered IGA as neutrophil engagers to fight cancer. The company is based in Boston, MA. TigaTx is backed by excellent investors and has an accomplished scientific advisory board. It was founded by Jeanette Leusen and the CEO is Anne Altmeyer. | Direttore/Membro del Consiglio | 01/09/2009 |
Precedenti posizioni note di Sonia Gulati
| Società | Posizione | Fine |
|---|---|---|
Actinobac Biomed, Inc.
 Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Direttore/Membro del Consiglio | 30/09/2021 |
1200 Pharma LLC
 1200 Pharma LLC Pharmaceuticals: MajorHealth Technology 1200 Pharma LLC engages in the provision of pre-clinical drug discovery and clinical approval timelines. The company is headquartered in Pasadena, CA. | Direttore/Membro del Consiglio | 31/08/2021 |
Pinpoint Therapeutics, Inc.
 Pinpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pinpoint Therapeutics, Inc. provides cancer treatment. The firm specializes in developing novel treatments for cancer. The company was founded by Jeffrey Winkler and Ravi Amaravadi in 2018 and is headquartered in Philadelphia, PA. | Direttore/Membro del Consiglio | 31/08/2021 |
New York Ventures
 New York Ventures Investment ManagersFinance New York Ventures (New York State Innovation) is a venture capital subsidiary of Empire State Development Corp. The firm is headquartered in New York. | Investitore di Private Equity | 31/12/2018 |
Formazione di Sonia Gulati
| Barnard College | Undergraduate Degree |
| Columbia University School of the Arts | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Health Technology |
New York Ventures
New York Ventures Investment ManagersFinance New York Ventures (New York State Innovation) is a venture capital subsidiary of Empire State Development Corp. The firm is headquartered in New York. | Finance |
1200 Pharma LLC
1200 Pharma LLC Pharmaceuticals: MajorHealth Technology 1200 Pharma LLC engages in the provision of pre-clinical drug discovery and clinical approval timelines. The company is headquartered in Pasadena, CA. | Health Technology |
Accelerate Long Island (Venture Capital)
Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island/venture capital/ (Accelerate Long Island (Venture Capital)) is a venture capital firm, a subsidiary of Accelerate Long Island, Inc founded in 2016. The firm is headquartered in Melville, New York. | Finance |
Pinpoint Therapeutics, Inc.
Pinpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pinpoint Therapeutics, Inc. provides cancer treatment. The firm specializes in developing novel treatments for cancer. The company was founded by Jeffrey Winkler and Ravi Amaravadi in 2018 and is headquartered in Philadelphia, PA. | Health Technology |
Leukovet
Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Health Technology |
TigaTx, Inc.
TigaTx, Inc. BiotechnologyHealth Technology TigaTx, Inc. is a biotechnology company that focuses on developing first-in-class, engineered IGA as neutrophil engagers to fight cancer. The company is based in Boston, MA. TigaTx is backed by excellent investors and has an accomplished scientific advisory board. It was founded by Jeanette Leusen and the CEO is Anne Altmeyer. | Health Technology |
- Borsa valori
- Insiders
- Sonia Gulati
